Skip to content
Open access · CC-BY via OpenAlex

Targeting autophagy in disease: established and new strategies

Muhammed Koçak, Saba Ezazi Erdi, Guillem Jorba, Inés Maestro, Judith Farrés, Vladimir Kirkin, Ana Martínez, Ole Pleß

Autophagy · 2021 · ▲ 235 citations

Abstract

Macroautophagy/autophagy(definition) is an evolutionarily conserved pathway responsible for clearing cytosolic aggregated proteins, damaged organelles or invading microorganisms. Dysfunctional autophagy leads to pathological accumulation of the cargo, which has been linked to a range of human diseases, including neurodegenerative diseases, infectious and autoimmune diseases and various forms of cancer. Cumulative work in animal models, application of genetic tools and pharmacologically active compounds, has suggested the potential therapeutic value of autophagy modulation in disease, as diverse as Huntington, Salmonella infection, or pancreatic cancer. Autophagy activation versus inhibition strategies are being explored, while the role of autophagy in pathophysiology is being studied in parallel. However, the progress of preclinical and clinical development of autophagy modulators has been greatly hampered by the paucity of selective pharmacological agents and biomarkers to dissect their precise impact on various forms of autophagy and cellular responses. Here, we summarize established and new strategies in autophagy-related drug discovery and indicate a path toward establishing a more efficient discovery of autophagy-selective pharmacological agents. With this knowledge at hand, modern concepts for therapeutic exploitation of autophagy might become more plausible.Abbreviations: ALS: amyotrophic lateral sclerosis; AMPK: AMP-activated protein kinase; ATG: autophagy-related gene; AUTAC: autophagy-targeting chimera; CNS: central nervous system; CQ: chloroquine; GABARAP: gamma-aminobutyric acid type A receptor-associated protein; HCQ: hydroxychloroquine; LYTAC: lysosome targeting chimera; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MTOR(definition): mechanistic target of rapamycin(definition) kinase; NDD: neurodegenerative disease; PDAC: pancreatic ductal adenocarcinoma; PE: phosphatidylethanolamine; PIK3C3/VPS34: phosphatidylinositol 3-kinase catalytic subunit type 3; PtdIns3K: class III phosphatidylinositol 3-kinase; PtdIns3P: phosphatidylinositol 3-phosphate; PROTAC: proteolysis-targeting chimera; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; SQSTM1/p62: sequestosome 1; ULK1: unc-51 like autophagy activating kinase 1.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1080/15548627.2021.1936359
Canonical
link ↗
Fetched
2026-11-11 MST

Cite this

APA
Koçak, M., Erdi, S.E., Jorba, G., Maestro, I., Farrés, J., Kirkin, V., Martínez, A., &amp; Pleß, O. (2021). Targeting autophagy in disease: established and new strategies. <em>Autophagy</em>. https://doi.org/10.1080/15548627.2021.1936359
Vancouver
Koçak M, Erdi SE, Jorba G, Maestro I, Farrés J, Kirkin V, et al. Targeting autophagy in disease: established and new strategies. Autophagy. 2021. doi:10.1080/15548627.2021.1936359.
BibTeX
@article{muhammed2021Target, title = {Targeting autophagy in disease: established and new strategies}, author = {Muhammed Koçak and Saba Ezazi Erdi and Guillem Jorba and Inés Maestro and Judith Farrés and Vladimir Kirkin and Ana Martínez and Ole Pleß}, journal = {Autophagy}, year = {2021}, doi = {10.1080/15548627.2021.1936359}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings